These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10799467

  • 1. Humoral immune response in chromoblastomycosis during and after therapy.
    Esterre P, Jahevitra M, Andriantsimahavandy A.
    Clin Diagn Lab Immunol; 2000 May; 7(3):497-500. PubMed ID: 10799467
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chromoblastomycosis with terbinafine: a report of four cases.
    Xibao Z, Changxing L, Quan L, Yuqing H.
    J Dermatolog Treat; 2005 Apr; 16(2):121-4. PubMed ID: 16019628
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study.
    Esterre P, Inzan CK, Ramarcel ER, Andriantsimahavandy A, Ratsioharana M, Pecarrere JL, Roig P.
    Br J Dermatol; 1996 Jun; 134 Suppl 46():33-6; discussion 40. PubMed ID: 8763467
    [Abstract] [Full Text] [Related]

  • 4. [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean] [Natural history of chromoblastomycosis in Madagascar and the [Natural history of chromoblastomycosis in Madagascar and the Indian Ocean].
    Esterre P, Andriantsimahavandy A, Raharisolo C.
    Bull Soc Pathol Exot; 1997 Jun; 90(5):312-7. PubMed ID: 9507759
    [Abstract] [Full Text] [Related]

  • 5. Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar1.
    Rasamoelina T, Maubon D, Andrianarison M, Ranaivo I, Sendrasoa F, Rakotozandrindrainy N, Rakotomalala FA, Bailly S, Rakotonirina B, Andriantsimahavandy A, Rabenja FR, Andrianarivelo MR, Cornet M, Ramarozatovo LS.
    Emerg Infect Dis; 2020 Jun; 26(6):1201-1211. PubMed ID: 32441639
    [Abstract] [Full Text] [Related]

  • 6. [An ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela].
    Oberto-Perdigón L, Romero H, Pérez-Blanco M, Apitz-Castro R.
    Rev Iberoam Micol; 2005 Mar; 22(1):39-43. PubMed ID: 15813682
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y, Huang X, Lu S, Hamblin MR, Mylonakis E, Zhang J, Xi L.
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [Abstract] [Full Text] [Related]

  • 8. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.
    Tanuma H, Hiramatsu M, Mukai H, Abe M, Kume H, Nishiyama S, Katsuoka K.
    Mycoses; 2000 Feb; 43(1-2):79-83. PubMed ID: 10838854
    [Abstract] [Full Text] [Related]

  • 9. Detection of circulating antibodies in patients affected by chromoblastomycosis by Cladosporium carrionii using double immunodiffusion.
    Villalba E, Yegres JF.
    Mycopathologia; 1988 Apr; 102(1):17-9. PubMed ID: 3138541
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J, Xi L, Lu C, Li X, Xie T, Zhang H, Xie Z, De Hoog S.
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [Abstract] [Full Text] [Related]

  • 11. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM, Ramos-Caro FA.
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [Abstract] [Full Text] [Related]

  • 12. Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.
    Azevedo CD, Bruña-Romero O, Marques SG, Nascimento FR, Pinto MC, Silva LA, Bouillet LE, Azevedo FS, Stoianoff MA.
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1791-7. PubMed ID: 24832023
    [Abstract] [Full Text] [Related]

  • 13. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
    Vidal MS, de Castro LG, Cavalecate SC, Lacaz Cda S.
    Rev Inst Med Trop Sao Paulo; 2003 Oct; 45(6):315-8. PubMed ID: 14762630
    [Abstract] [Full Text] [Related]

  • 14. Detection of antibodies in the sera of patients with chromoblastomycosis by counter immunoelectrophoresis. I. Preliminary results.
    Villalba E.
    J Med Vet Mycol; 1988 Feb; 26(1):73-4. PubMed ID: 3379541
    [Abstract] [Full Text] [Related]

  • 15. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy.
    Gimenes VM, Criado PR, Martins JE, Almeida SR.
    Mycopathologia; 2006 Aug; 162(2):97-101. PubMed ID: 16897587
    [Abstract] [Full Text] [Related]

  • 16. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK, Taborda PR, Sanzovo AD.
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chromoblastomycosis.
    Torres-Guerrero E, Isa-Isa R, Isa M, Arenas R.
    Clin Dermatol; 2012 Oct; 30(4):403-8. PubMed ID: 22682188
    [Abstract] [Full Text] [Related]

  • 20. Parenteral vitamin D(3) and oral terbinafine for refractory chromoblastomycosis.
    Hussain I, Rashid T, Haroon TS.
    Br J Dermatol; 2002 Apr; 146(4):704. PubMed ID: 11966710
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.